Joshua Makower

Joshua Makower (board member) discloses dealings in 17 companies, chiefly Aveo Pharmaceuticals, Inc., Ardelyx, Inc. and Eargo, Inc. Between 13 January 2016 and 28 June 2021, the trades on record add up to 74 filings.

In open-market terms, that means 46 purchases worth €136.2M on one side and 2 sales worth €597k on the other. Netting one side against the other leaves €135.6M of net buying. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 4 share grants.

In size, the median ticket on the buying side is €969k. 43 out of 43 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The latest filing, published on 30 June 2021, reports a transaction in NeueHealth, Inc. The last purchase on record was published on 7 December 2020, which is 2,144 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.